$ 391.87
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Strong margins and returns
About
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Target Price
The average target price of SYK is 426 and suggests 8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sug
